• Sarepta Therapeutics average return on tangible equity for 2023 was -134.22, a 57.66% decline from 2022.
• Sarepta Therapeutics average return on tangible equity for 2022 was -85.13, a 1.12% increase from 2021.
• Sarepta Therapeutics average return on tangible equity for 2021 was -86.09, a 43.6% decline from 2020.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.